Resmed (ASX: RMD) — Perfil da empresa, notícias e dados financeiros
ResMed is a health technology company focused on sleep apnea and chronic respiratory disorders, improving patient outcomes.
Resmed
Resmed is a medical device and digital health company that specializes in the development, manufacturing, and distribution of cloud-connected medical devices, software, and health solutions for sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. The company provides continuous positive airway pressure machines, mechanical ventilators, masks, accessories, and patient management software applications. Additionally, it offers out-of-hospital software solutions for home medical equipment providers, home health agencies, hospice care, and senior living facilities to streamline clinical workflows and care coordination across healthcare ecosystems.
Resumo
Operações
Produtos e/ou serviços de Resmed
- Sleep Apnea Therapy Devices: Production and global distribution of continuous positive airway pressure machines, bilevel devices, and auto-titrating airflow pressure generators. These connected flow generators deliver therapeutic pressurized air to treat obstructive sleep apnea and nocturnal hypoventilation.
- CPAP Masks and Accessories: Design and manufacturing of nasal, full face, and nasal pillow mask systems engineered for sleep therapy interface connection. Operations include replacement cushions, headgear, frame assemblies, tubing, and humidification chambers sold worldwide across consumer and clinical care markets.
- Non-Invasive and Invasive Mechanical Ventilators: Manufacturing of portable life-support mechanical ventilators and respiratory therapy hardware. Facilities supply life support and ventilation systems used for managing chronic obstructive pulmonary disease, neuromuscular disease, chest wall disorders, and pediatric respiratory conditions in clinical and home environments.
- Sleep and Respiratory Care Software Applications: Development and deployment of cloud-based patient management platforms and patient-facing monitoring applications. Systems enable healthcare professionals to remotely track therapy compliance, analyze efficacy data, Titrate settings, and manage clinical care workflows for sleep apnea and respiratory patients globally.
- Out-of-Hospital Software Solutions: Provision of electronic health record systems and administrative management software for home medical equipment businesses, home health agencies, hospice organizations, and senior living facilities. Software suites streamline billing, inventory tracking, clinical documentation, and point-of-care operations.
- Diagnostic and Titration Equipment: Supply of portable home sleep testing devices, laboratory titration software, and sleep diagnostic hardware. Products allow sleep clinics and physicians to record nocturnal physiological parameters, diagnose sleep-disordered breathing, and determine optimal therapeutic pressure settings.
equipe executiva do Resmed
- Michael J. FarrellCEO & Chairman
- Peter C. FarrellFounder, Chair Emeritus & Non-Executive Director
- Aaron BloomerChief Financial Officer
- Michael J. RiderChief Legal Officer & Secretary
- Brett A. SandercockAdvisor
- Justin LeongChief Product Officer
- Alastair RobertsonChief Information Officer
- Sallilyn SchwartzChief Communications & Investor Relations Officer
- Jim EllisChief Compliance Officer
- Yvonne-Katrin PucknatChief Marketing Officer
Últimas notícias sobre a Resmed
Comunicados recentes
O que a Resmed (RMD) comunicou ao mercado, do mais recente para o mais antigo.
- Statement of changes in beneficial ownership
- Statement of CDIs on issue - RMD
- Statement of changes in beneficial ownership
- Statement of changes in beneficial ownership
- Statement of changes in beneficial ownership
- Statement of changes in beneficial ownership
- Statement of changes in beneficial ownership
- Notice of Annual General Meeting Additional Materials
Histórico de dividendos
Dividendos por ação pagos pela Resmed, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2027(até o momento) | — | — | — | $0.7527 |
| FY2026 | $0.0852 | $0.2530 | — | $2.7381 |
| FY2025 | $0.0752 | $0.2256 | — | $2.4208 |
| FY2024 | $0.0681 | $0.2044 | — | $0.2725 |
| FY2023 | $0.0624 | $0.1873 | — | $0.2498 |
Principais indicadores financeiros
Resultados divulgados pela Resmed, em USD.
- Cap. de mercado
- 49,8 bi
- Receita (TTM)
- 5,7 bi
- P/L
- 23.0
- LPA (diluído, TTM)
- 1.5
- Dividend yield
- 6.8%
- Margem de lucro
- 27.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 5,8 bi | 2 bi | 1,6 bi | |
| 5,1 bi | 1,7 bi | 1,4 bi | |
| 4,7 bi | 1,4 bi | 1 bi | |
| 4,2 bi | 1,2 bi | 897,6 mi |